Alnylam Pharmaceuticals
ALNY
#728
Rank
C$48.78 B
Marketcap
C$364.61
Share price
-1.08%
Change (1 day)
-40.86%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend yield history for this company